There are 2934 resources available
4983 - Immunogenicity of BRCA1-deficient Ovarian Cancers is Driven through DNA Sensing and is Augmented by PARP Inhibition
Presenter: Marine Bruand
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
1983 - Prognostic and predictive impact of high tumor mutation burden (TMB) in solid tumors: a systematic review and meta-analysis
Presenter: Mairead McNamara
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
2699 - Comparison of Platforms for Determining Tumor Mutational Burden (TMB) in Patients With Non-Small Cell Lung Cancer (NSCLC)
Presenter: Jonathan Baden
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
2434 - Prevalence and prognostic effect of high tumor mutation burden (TMB-H) across multiple less common solid cancers using a real-world dataset
Presenter: Daniel Backenroth
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
Discussion led by Chair
Presenter: Javier Puente
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
Webcast
1085 - CCTG IND 232: A Phase II Study of Durvalumab With or Without Tremelimumab in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Presenter: Sebastien Hotte
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1612 - Efficacy and Safety of Nivolumab in Combination With Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer in CheckMate 9KD
Presenter: Karim Fizazi
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
Poster Discussion – Genitourinary tumours, prostate - Invited Discussant LBA51, LBA52, 848PD, 849PD and 855PD
Presenter: Cora Sternberg
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Slides
Webcast
5387 - Health-related quality of life (HRQL) in a randomized phase 3 trial of enzalutamide with standard first line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial
Presenter: Martin Stockler
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
5443 - Harmonization study of Tumour Mutational Burden determination in Non-Small-Cell Lung Cancer (NSCLC)
Presenter: Eva M Garrido-Martin
Session: Poster Discussion 1 – Translational research
Resources:
Abstract